19 June 2018 - Osteoarthritis (OA) is a growing problem around the world. An estimated 10% to 15% of all adults over the age of 60 have some degree of OA, and the condition is becoming more prevalent due to population ageing and an increase in relate...
19 June 2018 - Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) has gained US approval for its Isoproterenol Hydrochloride Injection, the company announced on Tuesday.The US Food and Drug Administration (FDA) has approved Amphastar's abbreviated new...
19 June 2018 - - A new study, published in the Journal of Diabetes Research, has found that use of Livongo for Daiabetes from Mountain View, California-based personalized medicine specialist Livongo, significantly improves the health of people with t...
19 June 2018 - - Bothell, Washington-based cancer treatment developer Seattle Genetics, Inc. (NASDAQ: SGEN) has dosed the first patient in the phase 2 innovaTV 204 clinical trial evaluating the efficacy, safety and tolerability of tisotumab vedotin a...
19 June 2018 - - Dr. Frank Morschhauser of the Centre Hospitalier Universitaire Régional de Lille, Unité GRITA, Lille, France has presented results of RELEVANCE, a Phase III efficacy and safety study of lenalidomide plus rituximab versu...